Saratov JOURNAL of Medical and Scientific Research
Home

Characteristics of myocardial revascularization in patients with acute coronary syndrome in the post-COVID period

Year: 2025, volume 21 Issue: №2 Pages: 167-172
Heading: Cardiology Article type: Original article
Authors: Kozik V.A., Shpagina L.A., Shpagin I.S.
Organization: Novosibirsk State University
Summary:

Objective: to evaluate the features of myocardial revascularization in patients with acute coronary syndrome (ACS) in the post-COVID period. Material and methods. A total of 114 patients with ACS and a history of new coronavirus infection (NCI) (group 1). The comparison group included 111 patients with ACS without a history of NCI (group 2). All patients in both groups underwent percutaneous transluminal coronary angioplasty (PTCA) with stenting on the first day. Results. A significant difference between the groups was noted in the frequency of PTCA with stenting, taking into account the age aspect: for patients in the age group over 65 years: p=0.031, relative risk (RR) 0.717 ([95% confidence intervals — Cl 0.518-0.991]). ACS in the post-COVID period was associated with damage to the right coronary artery (p<0.001, RR 1.629 [95% Cl 1.251-2.120]) and statistically significantly increased the risk of developing reperfusion syndrome, namely the occurrence of cardiogenic shock on the operating table (p=0.023, RR 1.553 [95% Cl 1.162-2.075]), AV blocks (p=0.034, RR 1.775 [95% Cl 1.322-2.383]) and bradycardia (p=0.021, RR 1.707 [95% Cl 1.280-2.276]). Conclusion. Patients with ACS in the post-COVID period more often experience manifestations of reperfusion syndrome after revascularization compared to patients without previous NCI.

Keywords: acute coronary syndrome, new coronavirus infection, post-COVID period, post-COVID syndrome, revascularization parameters

Bibliography:
1. Gaidai О, Cao Y, Loginov S. Global cardiovascular diseases death rate prediction. Curr Probl Cardiol. 2023;48 (5):101622. DOM 0.1016/j.cpcardiol.2023.101622
2. Acute coronary syndrome without ST-segment elevation electrocardiogram. Clinical guidelines. 2024. URL: https:// cr.minzdrav.gov.ru/preview-cr/154_4 (25 Apr 2025).
3. Acute myocardial infarction with ST-segment elevation electrocardiogram. Clinical guidelines. 2024. URL: https:// scardio.ru/content/Guidelines/11012025.pdf (25 Apr 2025).
4. Alekyan BG, Boytsov SA, Ganyukov VI, et al. Impact of the COVID-19 pandemic on myocardial revascularization in patients with acute coronary syndrome in the Russian Federation. Rational Pharmacotherapy in Cardiology. 2022; (4):411—9. DOI:10.20996/1819-6446-2022-08-03.
5. Jassat W, Reyes LF, Munblit D, et al. Long COVID in low-income and middle-income countries: the hidden public health crisis. Lancet. 2023;402 (10408):1115-7. DOI:10.1016/S0140-6736(23)01685-9
6. Temporary clinical guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19), version 18 (26 Oct 2023). URL: https://static-0.minzdrav.gov.ru/system/at-tachments/attaches/000/064/610/original/BMP_COVID-19_ V18.pdf (25 Apr 2025).
7. Qi F, Qian S, Zhang S, et al. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526 (1):135-40. DOI:10.1016/j.bbrc.2020.03.044
8. Baycan OF, Barman HA, AticiA, et al. Evaluation of biven-tricular function in patients with COVID-19 using speckle tracking echocardiography. Int J Cardiovasc Imaging. 2021 ;37(1): 135-44. DOI:10.1007/sl 0554-020-01968-5
9. He LP, Tang XY, Ling WH, et al. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: A meta-analysis of longitudinal studies. Heart. 2010;96 (5):339-46. DOI:10.1136/hrt.2009.174912
10. Meyer P, Degrauwe S, Van Delden C, et al. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J. 2020;41 (19):1860. DOI:10.1093/eurheartj/ehaa306
11. Eguiburu-Jaime JL, Delmiro A, Lalueza A, et al. Soluble fms-like tyrosine kinase-1: A potential early predictor of respiratory failure in COVID-19 patients. Clin Chem Lab Med. 2021 ;59 (7):e289-92. DOI:10.1515/cclm-2021-0126
12. Orlova NV, Lomaichikov VV, Chuvarayan GA, et al. Study of clinical and diagnostic parameters in patients with acute coronary syndrome who underwent COVID-19. Medical Alphabet. 2021 ;(23):53-7. DOI:10.33667/2078-5631-2021-23-53-57
13. Alfaro Е, Diaz-Garcia Е, Garcia-Tovar S, et al. En-dothelial dysfunction and persistent inflammation in severe post-COVID-19 patients: implications for gas exchange. ВМС Med. 2024;(1):242. DOI:10.1186/s12916-024-03461-5
14. Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Cardioimmunology of arrhythmias: The role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;19 (1):63-4. DOI:10.1038/s41577-018-0098-z
15. Pinto AA, Carroll LS, Nar V, et al. CNS inflammatory vas-culopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19. Neurol Neuroimmunol Neuroinflamm. 2020;7 (5):e813. DOM 0.1212/NXI.0000000000000813
16. Raposeiras-Roubin S, Abu-Assi E, Cabanas-Grandio P, et al. Walking beyond the GRACE (Global Registry of Acute Coronary Events) model in the death risk stratification during hospi-talization in patients with acute coronary syndrome: what do the AR-G (ACTION [Acute Coronary Treatment and Intervention Outcomes Network] Registry and GWTG [Get With the Guidelines] Database), NCDR (National Cardiovascular Data Registry), and EuroHeart Risk Scores Provide? JACC Cardiovasc Interv. 2012;5 (11):1117-25. DOI:10.1016/j.jcin.2012.06.023
17. Kozik VA, Shpagina LA, Shpagin IS, Loktin EM. Features of echocardiography parameters in acute coronary syndrome combined with post-COVID syndrome. Saratov Journal of Medical Scientific Research. 2025;21 (1):43-9. DOI:10.15275/ssmj2101043

AttachmentSize
2025_02_167-172.pdf359.28 KB
All articles of the authors: Kozik V.A., Shpagin I.S., Shpagina L.A.

No votes yet